Review edoxaban prescriptions for cost-effective alternatives.
Betsi Cadwaladr University Health Board seeks a service to review patients prescribed edoxaban in primary care, aiming to switch them to a more cost-effective alternative. The scope involves clinical review and potential medication changes. The buyer is a Welsh health board serving the local population. Requirements likely include clinical expertise in anticoagulation and primary care experience. The contract value is not specified, but the focus on cost savings suggests a moderate scale.